These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8796337)

  • 21. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
    Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
    Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma prolactin levels in ovariectomized thyroidectomized rats treated with estrogen.
    Pan JT; Chen CW
    Endocrinology; 1990 Jun; 126(6):3146-52. PubMed ID: 1972060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of reference values for endocrine tests. II: Hyperprolactinemia.
    Le Moli R; Endert E; Fliers E; Mulder T; Prummel MF; Romijn JA; Wiersinga WM
    Neth J Med; 1999 Aug; 55(2):71-5. PubMed ID: 10474275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms.
    Badawy SZ; Moses A; Streeten D; Marshall L; Marlin D; Notman D
    Int J Fertil; 1983; 28(4):213-8. PubMed ID: 6142012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmotic control of the release of prolactin and thyrotropin in euthyroid subjects and patients with pituitary tumors.
    Sowers JR; Hershman JM; Showsky WR; Carlson HE; Park J
    Metabolism; 1977 Feb; 26(2):187-92. PubMed ID: 401926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of postinhibitory increase in plasma prolactin by domperidone in patients with prolactin secreting adenoma.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Endocrinol Jpn; 1985 Dec; 32(6):811-7. PubMed ID: 3938732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small dose of domperidone potentiated the effects of TRH and serotonin on prolactin release in ovariectomized, estrogen-treated rats.
    Pan JT; Teo KL
    Neuroendocrinology; 1989 Oct; 50(4):387-91. PubMed ID: 2510048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
    Klijn JG; Lamberts SW; de Jong FH; Birkenhäger JC
    Fertil Steril; 1981 Feb; 35(2):155-61. PubMed ID: 6781936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
    Seki K; Kato K
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
    Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
    J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.